BRIEF-YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA Industries

Reuters01-05

Jan 5 (Reuters) - CEA Industries Inc BNC.O:

YZI LABS RESPONDS TO ADOPTION OF POISON PILL AND DEFENSIVE BYLAW AMENDMENTS BY CEA INDUSTRIES
YZILABS: REVIEWING THE RECENT ACTIONS TAKEN BY BNC IN RESPONSE TO YZI’S GROUP FORMATION AND LAUNCH OF A CONSENT SOLICITATION PROCESS
YZILABS: “HAS NEVER CONSIDERED AN ALTERNATIVE TOKEN FOR THE COMPANY’S DIGITAL ASSET TREASURY STRATEGY, NOR LAUNCHED COMPETITIVE DAT VENTURES"

Source text: ID:nGNX2nLxvm

Further company coverage: BNC.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2601888217?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-05 22:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601888217","market":"fut","top_or_hot":-1,"title":"BRIEF-YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA Industries","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA Industries</title></head><body><p><span>Jan 5 (Reuters)</span><span> - </span>CEA Industries Inc <span>BNC.O</span>:</p><ul><li><p>YZI LABS RESPONDS TO ADOPTION OF POISON PILL AND DEFENSIVE BYLAW AMENDMENTS BY CEA INDUSTRIES</p></li><li><p>YZILABS: REVIEWING THE RECENT ACTIONS TAKEN BY BNC IN RESPONSE TO YZI’S GROUP FORMATION AND LAUNCH OF A CONSENT SOLICITATION PROCESS</p></li><li><p>YZILABS: “HAS NEVER CONSIDERED AN ALTERNATIVE TOKEN FOR THE COMPANY’S DIGITAL ASSET TREASURY STRATEGY, NOR LAUNCHED COMPETITIVE DAT VENTURES\"</p></li></ul><p>Source text: <span>ID:nGNX2nLxvm</span></p><p>Further company coverage: <span>BNC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA Industries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA Industries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-05 22:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA Industries</title></head><body><p><span>Jan 5 (Reuters)</span><span> - </span>CEA Industries Inc <span>BNC.O</span>:</p><ul><li><p>YZI LABS RESPONDS TO ADOPTION OF POISON PILL AND DEFENSIVE BYLAW AMENDMENTS BY CEA INDUSTRIES</p></li><li><p>YZILABS: REVIEWING THE RECENT ACTIONS TAKEN BY BNC IN RESPONSE TO YZI’S GROUP FORMATION AND LAUNCH OF A CONSENT SOLICITATION PROCESS</p></li><li><p>YZILABS: “HAS NEVER CONSIDERED AN ALTERNATIVE TOKEN FOR THE COMPANY’S DIGITAL ASSET TREASURY STRATEGY, NOR LAUNCHED COMPETITIVE DAT VENTURES\"</p></li></ul><p>Source text: <span>ID:nGNX2nLxvm</span></p><p>Further company coverage: <span>BNC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4086","symbol_name":"建筑产品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60UV:1","article_id":"2601888217","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601888217","pubTimestamp":1767622353,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA IndustriesJan 5 (Reuters) - CEA Industries Inc BNC.O:YZI LABS RESPONDS TO ADOPTION OF POISON PILL AND DEFENSIVE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4086":"建筑产品","BNC":"CEA Industries Inc."},"translate_title":"简介-YZi Labs回应CEA Industries采用毒丸计划和防御性细则修正案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNC":0.9},"content_text":"BRIEF-YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA IndustriesJan 5 (Reuters) - CEA Industries Inc BNC.O:YZI LABS RESPONDS TO ADOPTION OF POISON PILL AND DEFENSIVE BYLAW AMENDMENTS BY CEA INDUSTRIESYZILABS: REVIEWING THE RECENT ACTIONS TAKEN BY BNC IN RESPONSE TO YZI’S GROUP FORMATION AND LAUNCH OF A CONSENT SOLICITATION PROCESSYZILABS: “HAS NEVER CONSIDERED AN ALTERNATIVE TOKEN FOR THE COMPANY’S DIGITAL ASSET TREASURY STRATEGY, NOR LAUNCHED COMPETITIVE DAT VENTURES\"Source text: ID:nGNX2nLxvmFurther company coverage: BNC.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601888217","isCrawlerRequest":true}